Showing results (81-90 of 114) with videos related to
Sort By:
Pageof 12
Alcohol and Alcoholism (Oxford, Oxfordshire)|February 28, 2019
Assessment of alcohol consumption in depression follow-up using self-reports and blood measures including inflammatory biomarkersMari Archer, Olli Kampman, Aini Bloigu, et al.Psychiatry Research|January 15, 2010
Catechol-O-methyltransferase val108/158met genotype, major depressive disorder and response to selective serotonin reuptake inhibitors in major depressive disorderAri Illi, Eija Setälä-Soikkeli, Olli Kampman, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|December 8, 2010
Temperament profiles, 5-HT2A genotype, and response to treatment with SSRIs in major depressionKadri Andre, Olli Kampman, Eija Setälä-Soikkeli, et al.BMC Public Health|July 12, 2012
Relationships between depressive symptoms and self-reported unintentional injuries: the cross-sectional population-based FIN-D2D surveyKatariina Korniloff, Arja Häkkinen, Hannu J Koponen, et al.Psychiatric Genetics|December 20, 2012
No support for a role for BDNF gene polymorphisms rs11030101 and rs61888800 in major depressive disorder or antidepressant response in patients of Finnish originAri Illi, Merja Viikki, Outi Poutanen, et al.Human Psychopharmacology|May 26, 2007
Catechol-O-methyltransferase val108/158met genotype and response to antipsychotic medication in schizophreniaAri Illi, Olli Kampman, Kari Hänninen, et al.Nordic Journal of Psychiatry|March 6, 2015
SERT and NET polymorphisms, temperament and antidepressant responseKadri Andre, Olli Kampman, Ari Illi, et al.Translational Psychiatry|October 24, 2025
Meta-analyses of clozapine, norclozapine levels and their ratio across three genome wide association studiesSusanna Maria Rask, Anssi Solismaa, Ari Ahola-Olli, et al.Neuroscience Letters|September 16, 2006
Association between the C957T polymorphism of the dopamine D2 receptor gene and schizophreniaKari Hänninen, Heikki Katila, Olli Kampman, et al.Pharmacogenomics|November 26, 2016
INSIG2 polymorphism and weight gain, dyslipidemia and serum adiponectin in Finnish patients with schizophrenia treated with clozapineSuvi Koskinen, Olli Kampman, Anssi Solismaa, et al.Pageof 12